IL2RB and autoimmune disease: Suzuki’s research group has provided the early evidence that CD8+CD122+ T-cells maintain T cell homeostasis (14), whereas more recent studies have suggested that CD8+CD122+ T-cells are Tregs that suppress conventional T cell responses (14–20) and control autoimmune diseases (21, 22).